Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet

Shufei Zeng(Heidelberg University), Berthold Hocher(University of Potsdam), Yingquan Xiong(Heidelberg University), Bernhard K. Krämer, Ahmed A. Hasan(University of Potsdam), Yaochen Cao(Daqing City People's Hospital), Yao Xue(Heidelberg University), Ting Luo(Zhejiang University of Technology), Thomas Klein(Central Institute for Art History), Sandra Frankenreiter(University of Tübingen), Kai Bernd Stadermann(Bielefeld University), Chang Chu(Heidelberg University), Lianghong Yin(First Affiliated Hospital of Jinan University), Xiaoyi Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Denis Delić(Boehringer Ingelheim (Germany)), Xin Chen(The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture), Mohamed M. S. Gaballa(Benha University)
Biomedicine & Pharmacotherapy
December 27, 2021
Cited by 37


Related Papers